Management

Management https://www.benzinga.com/views/taxonomy/term/60 en CrowdStrike Boss Says CEOs Are Panic-Calling Their CISOs On Weekends Asking If AI Is Going To Kill Their Company: '...Really A Problem?' https://www.benzinga.com/markets/earnings/26/06/52992718/crowdstrike-boss-says-ceos-are-panic-calling-their-cisos-on-weekends-asking-if-ai-is-going-to-ki?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <p><strong>CrowdStrike Holdings Inc.</strong> <a class="ticker-link" data-ticker="CRWD" data-exchange="NASDAQ" href="https://www.benzinga.com/quote/CRWD" target="_blank" rel="noopener">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/CRWD">CRWD</a>)</a> delivered a record <a href="https://www.benzinga.com/markets/earnings/26/06/52987804/crowdstrike-delivers-beat-and-raise-q1-announces-4-for-1-stock-split">first-quarter fiscal 2027 earnings</a> beat-and-raise on Wednesday, driven by sheer enterprise panic as the frontier AI boom forces organizations to scramble for next-generation cyber defense.</p> <h2 class="wp-block-heading"><strong>The Weekend Panic & ‘Mythos’ Moment</strong><br /> <p data-path-to-node="3"></p> </h2> <p>During the conference call, founder and CEO <strong>George Kurtz</strong> painted a picture of the <a href="https://www.benzinga.com/markets/tech/26/06/52921289/software-stocks-rally-servicenow-crowdstrike-ai">urgency echoing through</a> corporate boardrooms. “I can tell you, CEO after CEO who called their CISOs on the weekend saying, is this thing really a problem?” Kurtz noted, likening the surge in AI-generated threat vectors to a cybersecurity “Y2K moment.”</p> <p>Describing the rapid adoption of generative tools as a “Mythos moment,” Kurtz declared that the intersection of cybersecurity and frontier AI has triggered a monumental paradigm shift. </p> <p>“For us, AI adoption is not a nice-to-have; it is an existential imperative across every geography and vertical,” he stated, cementing the Falcon platform as critical AI security infrastructure.</p> <p>“Now any human or agent can be a cyberhacker or worse, wage serious cyber attacks that threaten enterprise survival, nation state continuity, and critical infrastructure operations,” he added.</p> <div class="bz-read-next-block"<br /> data-variant="card"<br /> data-news-mode="manual" <p> ...</p></div><p><a href=https://www.benzinga.com/markets/earnings/26/06/52992718/crowdstrike-boss-says-ceos-are-panic-calling-their-cisos-on-weekends-asking-if-ai-is-going-to-ki?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel alt=CrowdStrike Boss Says CEOs Are Panic-Calling Their CISOs On Weekends Asking If AI Is Going To Kill Their Company: '...Really A Problem?'>Full story available on Benzinga.com</a></p> Analyst Color CRWD Earnings Equities Market Summary News Jim Cramer Management Markets CRWD News Analyst Color Earnings Equities Market Summary Management Markets Benzinga Thu, 04 Jun 2026 08:09:34 +0000 Rishabh Mishra 52992718 at https://www.benzinga.com Purna Pharmaceuticals Names Marc Verbruggen as Managing Director https://www.benzinga.com/pressreleases/26/06/g52992423/purna-pharmaceuticals-names-marc-verbruggen-as-managing-director?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="justify">Puurs, Belgium, June 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=EU_PJT125CjcLqQZqfADYrPyvmhEut7Dh6ugdbsPLsnWMGGaAF0VlGB_E2vGO_Kz6_ReqyTfvsixqHtuz_NstqJU_mfOVE1jsjy2iOvguBc=" rel="nofollow" target="_blank" rel="nofollow">Purna Pharmaceuticals</a> ("<u>Purna</u>"), a specialty contract development and manufacturing organization and portfolio company of Ampersand Capital Partners ("<u>Ampersand</u>"), today announced the appointment of Marc Verbruggen as Managing Director, effective June 1, 2026. Purna specializes in the development, manufacture and supply of liquid and semi-solid pharmaceutical products. Dr. Stefan Beyer, who is an Ampersand Executive Advisor and has served as Purna's Interim Managing Director, has joined the company's Board of Directors as its Chairman.</p> <p align="justify">Mr. Verbruggen joins Purna from Normec Healthcare Belgium, where he served as Managing Director. Previously, he was Group CEO of Qualiphar NV and held various site leadership roles at Novartis, Johnson & Johnson and Janssen Pharmaceutica. Mr. Verbruggen began his professional career at Monsanto as a production and process engineer after earning a Master's degree in Electro-Mechanical Engineering from KU Leuven and an MBA from Antwerp Management ...</p><p><a href=https://www.benzinga.com/pressreleases/26/06/g52992423/purna-pharmaceuticals-names-marc-verbruggen-as-managing-director?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel alt=Purna Pharmaceuticals Names Marc Verbruggen as Managing Director>Full story available on Benzinga.com</a></p> News Management Press Releases Thu, 04 Jun 2026 07:02:00 +0000 Globe Newswire 52992423 at https://www.benzinga.com Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development https://www.benzinga.com/pressreleases/26/06/g52992412/ona-therapeutics-raises-86-6-million-series-b-to-advance-first-in-class-adcs-into-clinical-develop?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <ul type="disc"> <li style="margin-top:6pt;"><em>Oversubscribed Series B financing co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from additional investors COFIDES and Korys, alongside all existing investors</em></li> <li style="margin-top:6pt;"><em>Proceeds to support clinical development of lead first-in-class program ONA-255 in breast cancer, toward clinical proof of concept, and advance ONA-389 in colorectal cancer</em></li> <li style="margin-top:6pt;"><em>Financing supports Ona's transition to a clinical-stage company and delivery of key clinical and regulatory milestones</em><br /><br /></li> </ul> <p align="justify">BARCELONA, Spain, June 04, 2026 (GLOBE NEWSWIRE) -- Ona Therapeutics ("Ona"), a global biopharmaceutical company pioneering first-in-class antibody-drug conjugates (ADCs) to address treatment-resistant cancers, today announced the closing of an oversubscribed $86.6 million Series B financing. The round was co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from additional investors COFIDES and Korys, alongside all existing investors Alta Life Sciences, Asabys Partners, Bpifrance, as part of the InnoBio investment strategy, CDTI through SICC Innvierte, FundPlus NV and Ysios Capital.</p> <p align="justify">The proceeds will be used to advance the clinical development of Ona's lead program, ONA-255, a first-in-class ADC initially focused on breast cancer, and to progress ONA-389, a second first-in-class ADC targeting colorectal cancer. ONA-255 is designed to address treatment-resistant tumor biology through a differentiated mechanism aimed at improving the therapeutic index compared to earlier approaches. ONA-389 will advance toward first-in-human studies, expanding Ona's pipeline in indications with significant unmet need. Ona Therapeutics currently retains full worldwide commercial rights to all its assets.</p> <p align="justify"><strong>Valerie Vanhooren, PhD, Co-Founder and Chief Executive Officer at Ona Therapeutics</strong>, <strong>said</strong><strong><em>:</em></strong><em> "The oversubscribed Series B marks an important step to advancing ONA</em><em>-</em><em>255 toward clinical proof of concept in breast cancer, while progressing early clinical development activities for ONA</em><em>-</em><em>389 in colorectal cancer. We are proud to have assembled a high-quality syndicate of investors who share our conviction in the differentiated science behind Ona's novel targets and their potential to address drug resistance. Supported by a highly experienced and talented team, this financing strengthens our commitment to tackling hard-to-treat cancers through meaningful innovation and addressing the significant unmet need faced by patients with limited treatment options."</em></p> <p align="justify"><strong>Jose Mesa, Partner at Columbus Venture ...</strong></p><p><a href=https://www.benzinga.com/pressreleases/26/06/g52992412/ona-therapeutics-raises-86-6-million-series-b-to-advance-first-in-class-adcs-into-clinical-develop?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel alt=Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development>Full story available on Benzinga.com</a></p> News Financing Management Press Releases Thu, 04 Jun 2026 07:00:00 +0000 Globe Newswire 52992412 at https://www.benzinga.com Bill Ackman Wants To Follow Buffett, Build The Next Berkshire Hathaway: 'It's Something I've Always Wanted To Do' https://www.benzinga.com/trading-ideas/long-ideas/26/06/52990322/bill-ackman-wants-to-follow-buffett-build-the-next-berkshire-hathaway-its-something-ive-?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <p><strong>Bill Ackman </strong>and <strong>Warren Buffett</strong> are two of the most well-known investors of the past 75 plus years. While Buffett is no longer the CEO of <strong>Berkshire Hathaway</strong> <a class="ticker-link" data-ticker="BRK-A" data-exchange="NYSE" href="https://www.benzinga.com/quote/BRK-A" target="_blank" rel="noopener">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/BRK">BRK</a>)</a><a class="ticker-link" data-ticker="BRK-B" data-exchange="NYSE" href="https://www.benzinga.com/quote/BRK-B" target="_blank" rel="noopener">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/BRK">BRK</a>)</a>, he built the conglomerate from <a href="https://www.benzinga.com/news/education/25/08/47430267/warren-buffett-turns-95-a-highlight-for-ever-decade-of-the-oracle-of-omahas-life">owning a textile business </a>into an insurance and investment powerhouse. Ackman is trying to accomplish the same.</p> <h2 class="wp-block-heading"><strong>Ackman Wants the Next Berkshire Hathaway</strong></h2> <p>Speaking at a recent All-In Podcast live event, <a href="https://www.benzinga.com/topic/bill-ackman">Ackman </a>highlighted the investment methods used by Buffett to build value for Berkshire Hathaway over time.</p> <p>Ackman <a href="https://x.com/theallinpod/status/2062144619744534571?t=960">said </a>Buffett was really the first to focus on the asset side more than the liability side of the insurance sector. The investor added that Buffett was able to build a compounding, tax-efficient machine by writing the risks on insurance, taking premiums, and then investing that money up front.</p> <p>"Buffett started with a crappy textile company," Ackman said</p> <p>For Ackman, he's attempting to start with <strong>Howard Hughes Holdings</strong> <a class="ticker-link" data-ticker="HHH" data-exchange="NYSE" href="https://www.benzinga.com/quote/HHH" target="_blank" rel="noopener">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/HHH">HHH</a>)</a>, a publicly traded commercial and residential real estate company.</p> <p>"The market doesn't like this thing."</p> <p>Ackman said ...</p><p><a href=https://www.benzinga.com/trading-ideas/long-ideas/26/06/52990322/bill-ackman-wants-to-follow-buffett-build-the-next-berkshire-hathaway-its-something-ive-?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel alt=Bill Ackman Wants To Follow Buffett, Build The Next Berkshire Hathaway: 'It's Something I've Always Wanted To Do'>Full story available on Benzinga.com</a></p> Bill Ackman BRK BRK/A BRK/B HHH Long Ideas META MSFT PS PSUS Warren Buffet Wizards Management Trading Ideas Insurance HHH MSFT US5949181045 BRK/B BRK BRK/A PS META PSUS Long Ideas Management Trading Ideas Insurance Benzinga Wed, 03 Jun 2026 22:48:02 +0000 Chris Katje 52990322 at https://www.benzinga.com Lotus Tech Announces Change to Board Composition https://www.benzinga.com/pressreleases/26/06/g52989568/lotus-tech-announces-change-to-board-composition?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. ("Lotus Tech" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/LOT" rel="nofollow">LOT</a>), a leading global intelligent and luxury mobility provider, today announced that the board of directors of the Company (the "Board") has appointed Mr. Joe Quan Zhang as a member and chairman of the Board and the compensation committee and the nominating and corporate governance committee of the Board, effective June 3, 2026.</p> <p align="start">Mr. Zhang succeeded Mr. Daniel Donghui Li, who had served on the Board since the inception of the Company. During his time as chairman, Mr. Li played a pivotal role in guiding the business as Lotus Tech broadened its product range and expanded into new markets. He has chosen to step down as a member of the Board, as chairman of the Board and from the Board committees, effective May 31, 2026, due to personal reasons.</p> <p align="start">The announcement comes on the heels of Lotus Tech entering its next phase of growth, executing its Focus 2030 strategy to strengthen its competitiveness as a global performance brand, and transform into a more flexible sustainable business model.</p> <p align="start">"This is an exciting time to be joining Lotus Tech. With the Focus 2030 strategy, the Company ...</p><p><a href=https://www.benzinga.com/pressreleases/26/06/g52989568/lotus-tech-announces-change-to-board-composition?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel alt=Lotus Tech Announces Change to Board Composition>Full story available on Benzinga.com</a></p> LOT News Management Press Releases Wed, 03 Jun 2026 21:30:00 +0000 Globe Newswire 52989568 at https://www.benzinga.com Peloton Announces Participation in the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference https://www.benzinga.com/pressreleases/26/06/g52986345/peloton-announces-participation-in-the-oppenheimer-26th-annual-consumer-growth-and-e-commerce-conf?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="left">NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/PTON" rel="nofollow">PTON</a>) today announced that Chief Executive Officer and President, Peter Stern, will participate in a fireside chat at the virtual Oppenheimer 26th Annual Consumer Growth and E-Commerce on Monday, June ...</p><p><a href=https://www.benzinga.com/pressreleases/26/06/g52986345/peloton-announces-participation-in-the-oppenheimer-26th-annual-consumer-growth-and-e-commerce-conf?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel alt=Peloton Announces Participation in the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference>Full story available on Benzinga.com</a></p> News PTON Management Press Releases Wed, 03 Jun 2026 20:05:00 +0000 Globe Newswire 52986345 at https://www.benzinga.com Wawanesa's first integrated report highlights how mutual insurer creates long-term value for members and communities https://www.benzinga.com/pressreleases/26/06/g52980278/wawanesas-first-integrated-report-highlights-how-mutual-insurer-creates-long-term-value-for-member?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>WINNIPEG, Manitoba, June 03, 2026 (GLOBE NEWSWIRE) -- Recognizing the strong connections between its financial and sustainability performance, and how they intersect with the growing impacts of climate change, Wawanesa has brought the two elements together in its first integrated report.</p> <p>Titled <a href="https://www.globenewswire.com/Tracker?data=mwG1tuUbT341AVtGUx4sVf0IwI1MrAmgjxMmb1z51jjej5reLicH7scG13NB-gE5xsFnyd9fur0Hg_eRgtyirONekkbmQxRT4nc7ZYFyPD4rMC1NdQF8Z4CJmxV0oxESgnYv9HkNXiMDoKGbbOXk9zP04zWoh1sOwixhEGv7VEc=" rel="nofollow" target="_blank" rel="nofollow"><em>Report to our Members 2025</em></a>, the publication provides a transparent view of how the mutual insurer operates, reinforcing its focus on building a resilient company that can continue meeting the needs of its members for generations to come. It also outlines the actions Wawanesa is taking to protect, strengthen, and enable communities so they can face the challenges of a changing world with confidence. The report's development was informed by the Office of the Superintendent of Financial Institutions' (OSFI) Guideline B-15: Climate Risk Management, along with other relevant principles, standards, frameworks, and regulations.</p> <p>Among the sustainability accomplishments highlighted in the <em>Report to our Members 2025 </em>is a 23% reduction in Scope 1 and 2 (location-based) greenhouse gas emissions from Wawanesa's operations relative to baseline levels, underscored by first-time limited third-party assurance of the 2025 figures.</p> <p>Financially, Wawanesa delivered record results last year, with consolidated premiums reaching $4.1 billion and consolidated ...</p><p><a href=https://www.benzinga.com/pressreleases/26/06/g52980278/wawanesas-first-integrated-report-highlights-how-mutual-insurer-creates-long-term-value-for-member?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel alt=Wawanesa's first integrated report highlights how mutual insurer creates long-term value for members and communities>Full story available on Benzinga.com</a></p> News Management Press Releases General Wed, 03 Jun 2026 17:12:30 +0000 Globe Newswire 52980278 at https://www.benzinga.com Precision Diagnostics and Medicine Market Expected to Reach USD 246.66 Billion by 2029 | MarketsandMarkets™ https://www.benzinga.com/pressreleases/26/06/g52972818/precision-diagnostics-and-medicine-market-expected-to-reach-usd-246-66-billion-by-2029-marketsandm?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>Delray Beach, FL, June 03, 2026 (GLOBE NEWSWIRE) -- The global <a href="https://www.globenewswire.com/Tracker?data=h_8pA7eZiS7B06rNnMONnmlZZhWOU1NvSHon7jDJQUET4Xe0UUG9vn8aWFfmU6qRyWQdkYRsqnefgtl3Bl3QGqw81huJyH31M83CFjqUO6KHjM2B-cKsU-HU0ZGInrFPSrO048D7vgSV-O-QqbVvqXV4W0trQcPOQ3u38d4l19Z6yUjC5bQKGj_EpGAuPnZx8Jxg1KupHBw5ukN45WjY39dFUmyvH1e5P2VKkCByFwy3gvRlasNZuryJA3qtx9bo2qN6Q71QnAHUaIw35CvQ2Dgl9ZsJFRLR-VqTrLB2NKWREtwliGP-UBlh6cBpHeDkKSBMcf5EB4wgZb-9d4jS-g==" rel="nofollow" target="_blank" rel="nofollow">precision diagnostics and medicine market</a> is projected to grow from USD 145.53 billion in 2024 to USD 246.66 billion by 2029, registering a CAGR of 11.1% during the forecast period. Increasing integration of artificial intelligence (AI) and machine learning (ML), rising collaborations between pharmaceutical and diagnostics companies, and growing adoption of direct-to-consumer testing are driving significant market expansion.</p> <p>The market is also benefiting from expanding applications of precision medicine beyond oncology into neurological, autoimmune, and rare diseases. In addition, wearable health technologies and advanced genetic testing solutions are enabling more personalized, data-driven, and preventive healthcare approaches globally.</p> <p><b>Download PDF Brochure: </b><a href="https://www.globenewswire.com/Tracker?data=Vua350udGQcmiiTxEY6ZkYXZW9lqo_Xb4zMNc8bNv1zgIWJ6fz1DW4ih88vbbNPg6XnrkucREUscoOr6eHnf9Hr15aD7dleai1MgUWmKqhFHE9EAJdRbFYIn7cbbuOptxbyROkB-9nJeZ3lmjPAwiTI3C5vCSSGLjZTOMBSr54oPjIuNg4SlycaZAxDXVz_A1XgBIb812VwLzGZkA0Mu0Cszp4FWRQg8EDIpH65jSDPUUlWfwo4BZDUoWv5LgNK7ndWnO4OAzMA4BTFsS2tcLMO_m3SaLs6jYseusBhRfM4p3fOTTTQyghOYnCahawVKu2YtmLR1luDWXyKsLIuqGg==" rel="nofollow" target="_blank" rel="nofollow"><b>https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=215185595</b></a></p> <p><b>What Is Driving Growth in the Precision Diagnostics and Medicine Market?</b><br />The growing integration of AI and ML technologies is significantly improving the accuracy and efficiency of precision healthcare solutions. AI-powered platforms are helping healthcare providers analyze complex genomic and clinical datasets to develop personalized treatment plans and improve therapeutic outcomes.</p> <p>Innovations such as AI-based cancer recurrence prediction tools and machine learning models for matching therapies to patient-specific tumor profiles are accelerating the adoption of precision diagnostics. Pharmaceutical and diagnostics companies are increasingly investing in these technologies to improve clinical decision-making and expand access to personalized therapies.</p> <p><b>Why Is Genetic Testing Becoming Increasingly Important?</b><br />The genetic testing segment held the largest share of the precision diagnostics market in 2023 due to increasing research investments and growing demand for advanced genomic testing solutions. These tests help identify genetic variations associated with disease diagnosis, prognosis, and therapy selection.</p> <p>Healthcare providers are increasingly utilizing genetic and biomarker testing to support precision treatment decisions across oncology, rare diseases, and neurological disorders. The growing emphasis on early diagnosis and targeted therapies is expected to further strengthen demand for precision diagnostics globally.</p> <p><b>Why Does Oncology Continue to Lead the Precision Medicine Market?</b><br />The oncology segment accounted for ...</p><p><a href=https://www.benzinga.com/pressreleases/26/06/g52972818/precision-diagnostics-and-medicine-market-expected-to-reach-usd-246-66-billion-by-2029-marketsandm?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel alt=Precision Diagnostics and Medicine Market Expected to Reach USD 246.66 Billion by 2029 | MarketsandMarkets™>Full story available on Benzinga.com</a></p> News Management Analyst Ratings Press Releases Wed, 03 Jun 2026 14:30:00 +0000 Globe Newswire 52972818 at https://www.benzinga.com Carina Davidson to Lead H/Advisors in the U.S. as Chief Executive Officer https://www.benzinga.com/pressreleases/26/06/g52971149/carina-davidson-to-lead-hadvisors-in-the-u-s-as-chief-executive-officer?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=80N0cXCz1qMhfWKj15YzP5LUPYBdlt4StQDzUfwBzsI6Lwjp4ahIWmAGH32JHDc-XsOjcWo_GQJf1ksM15t7G1Xp6poMkrmGUxL384yR4Is=" rel="nofollow" target="_blank" rel="nofollow">H/Advisors</a> today announced Carina Davidson as Chief Executive Officer of H/Advisors in the U.S. With offices across New York, Chicago, Houston, Los Angeles, Washington and San Francisco, this cements the next phase of growth for the Havas-owned strategic communications firm in the United States. She previously served as Interim CEO and President and held various leadership roles during her nearly 30-year tenure at the firm, which earlier this month transitioned to H/Advisors from H/Advisors Abernathy as part of a global rebrand.</p> <p><img alt="Abernathy-Carina-Davidson_1000x1000px" data-mce-style="display: block; margin-left: auto; margin-right: auto;" height="600" src="https://ml.globenewswire.com/Resource/Download/2618750f-2eb2-41d8-9823-f7d6b24749a4/abernathy-carina-davidson-1000x1000px.png" style="display:block; margin-left:auto; margin-right:auto;" width="600" data-dpi="144" data-caption="Carina Davidson to Lead H/Advisors in the U.S. as Chief Executive Officer" data-filename="Abernathy-Carina-Davidson_1000x1000px.png" /></p> <p>Davidson's appointment concludes a national search that considered both internal and external candidates. A seasoned communications expert, Davidson brings over thirty years of practitioner experience to the CEO position, advising Boards and senior executives on communications strategies surrounding critical, high-stakes moments. She has depth and range across corporate communications, investor relations, crisis management and M&A. In addition to her professional responsibilities, Davidson is a member of the Board of Trustees of Blair Academy and a professional mentor for Women ...</p><p><a href=https://www.benzinga.com/pressreleases/26/06/g52971149/carina-davidson-to-lead-hadvisors-in-the-u-s-as-chief-executive-officer?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel alt=Carina Davidson to Lead H/Advisors in the U.S. as Chief Executive Officer>Full story available on Benzinga.com</a></p> News Management Press Releases Wed, 03 Jun 2026 14:00:50 +0000 Globe Newswire 52971149 at https://www.benzinga.com HydroGraph Advances Dr. Suhao Li to Chief Technology Officer https://www.benzinga.com/pressreleases/26/06/g52968871/hydrograph-advances-dr-suhao-li-to-chief-technology-officer?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p><em>Promotion Recognizes Important Development of HydroGraph Graphene Products, Alignment of Scientific Programs with Technology Development and Research Priorities</em></p> <p><em>Company Provides Balance Sheet Updates, Cash at More than $41 Million </em></p> <p align="justify">AUSTIN, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=kGN1uEgRmGlMP-ukd46I5nc5LwtOES2o-bO58P_fOtVo15yV-E8DdFfkJNh-DFUqgrxOhzqebXvxaNmdKyXlI4SBhBoibqQXsldMLdfz8DJEQan6vyK4Hcw69TtbYiolenmcrZHiehSMHlXpduSZUZD-JYR61kgbrlHHhNyGNjZH9ETEaCrTI5V9hO_KPe2lOg0F-7ulXVwO7zsrvjFVslYl15lkhGh5o_Qgt_VFFo3hAyWjPoUZBYXtmwWbLntxhWk71I079gzvD3gpMw7LX7MGQ-Av_f6vxq94xesIwP1Q5CEPUtMMRW1ZUKL9Pk2_sN2i4sQBeZcIUHWQXu5IZ10l9ssBc4g6S0orOlu8IJUVcP1wYmIKJVVup722Gha5BXwYY5-3IIsfuSTpMP9FA-A6OF1O8viMdVmdXQT4JcmFzpjEE4eZU6twlHI6_U9bQwwiarsHFdoi92qGUzjPxA==" rel="nofollow" target="_blank" rel="nofollow"><u>HydroGraph Clean Power Inc.</u></a> (CSE:<a class="ticker" href="https://www.benzinga.com/quote/HG" rel="nofollow">HG</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/quote/HGRAF" rel="nofollow">HGRAF</a>) ("HydroGraph" or the "Company") today announced the promotion of Dr. Suhao Li to Chief Technology Officer. In this role, Dr. Li will lead HydroGraph's global technology, innovation strategy, research and development, product commercialization, intellectual property, and process scale-up initiatives, driving the Company's long-term competitive position.</p> <p align="justify">Dr. Li joined the Company in 2024, serving as Laboratory Director at the Company's Manchester, U.K. site, located in the <a href="https://www.globenewswire.com/Tracker?data=dKvfJwhLiVKRN8P4mt-MGU8k4IAlr5WFfz6SgZMaEql-hEGKQdTRlE0wce8JQGz27y7M4lP08_3WISRpjuLLoBZwc4D9B7TybKp9egQ-8tNsR4pHHvDbIZugixLEN29c-qOAUSHw_71Sa6W2zShUZ2Ka1e5LMGf1Ase6UATZrmbCgxqyiw0qVWWc4WsS4l7D9hYW3hzzXCyc3Hk8oLtHMUEn1fO9r8zdhZHs66A3C0I9133cPAK3fkXnlV4Y6tPWMLlUaP4hizFntgHWdQx74SmiyNt9DFbTN4C3sKNRcVyYu4Xc3E9z65yPYOOoLak2bzIU3xE0RVFgLbeqb1s42amWnX_VM7kRsI0GzmXa7qlKGgE5pzt-2eMESzPlrAv_2zDj1uc3DiDO0WB8mXhQ9PXRiIGnJl6h4NuCIWTK3Lb5ZTUzBzuRLKVeJA9hqOXBwepeX0c_H6xNaWrJxlQQNKeN_Mz4CRMWjcvqip0IoGgvAuckHSmDSDHJX31z2hXx" rel="nofollow" target="_blank" rel="nofollow"><u>Graphene Engineering and Innovation Centre</u></a> (GEIC). Previously, he was a senior scientist in advanced materials at Versarien, plc, where he contributed to the development and commercialization of graphene-enabled technologies across a broad range of applications, including plastics, composites, elastomers, coatings, lubricants, conductive inks, and aerogels for a range of commercial and defense industry applications. He holds a PhD in Materials Science from the National Graphene Institute at the University of Manchester, where his research focused on graphene-enhanced elastomer composites.</p> <p align="justify">"Dr. Li has transitioned HydroGraph's innovation programs from pure science to commercial application driven by customer development engagements across diverse global end markets," said Kjirstin Breure, President and Chief Executive Officer of HydroGraph. "His approach to rigorous development has demonstrated how high-purity, batch-consistent graphene provides critical performance improvements across both commercial and defense applications. His leadership has been instrumental in positioning HydroGraph to be a supplier for graphene in real-world applications."</p> <p align="justify">Said Dr. Li: "Over the past decade, I have seen graphene evolve from a breakthrough discovery into a material with real commercial potential by closing the gap between scientific promise and successful industrial adoption. One of the key factors has been the development of high-quality synthetic graphene that can meet the rigorous industrial requirements for both quality and batch consistency necessary to support the adoption of this new supermaterial.</p> <p align="justify">"During my tenure at HydroGraph, we have identified high-value applications, documented performance in real-world systems, built our intellectual property portfolio, and established a path to market for our graphene. Our focus has been clear: turn technical capability into measurable outcomes and move promising technologies from the lab into the market."</p> <p align="justify">Under Dr. Li's leadership, the Company's application development efforts have spanned multiple industries and material systems. Examples include:</p> <p align="justify"><em>Mechanical Reinforcement of Plastics</em></p> <p align="justify">One ...</p><p><a href=https://www.benzinga.com/pressreleases/26/06/g52968871/hydrograph-advances-dr-suhao-li-to-chief-technology-officer?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel alt=HydroGraph Advances Dr. Suhao Li to Chief Technology Officer>Full story available on Benzinga.com</a></p> CSE:HG HGRAF News Management Press Releases Wed, 03 Jun 2026 13:30:02 +0000 Globe Newswire 52968871 at https://www.benzinga.com Source Logistics Appoints Bart Bullard as Chief Technology Officer to Strengthen Leadership Team and Support Rapid Expansion https://www.benzinga.com/pressreleases/26/06/g52968866/source-logistics-appoints-bart-bullard-as-chief-technology-officer-to-strengthen-leadership-team-a?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="left">HOUSTON, June 03, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=jxDy6J7rf9rAU9KL55QWTK2tpd0tsSCPnCVxwJ2aRqRn-2K2tDjkd1aZOsTLo1Zcu3b3caRzSHwn3nC0mTr0CIWJoU-lY4fy89t66fee737NTAN4xO-JFd2uEica5pHf_sntf3c8V3T5DmokoVeu0RKS4iupZq39A96QOupXWVXRySN5iSQR2B-9MjzHpvShra7MH7zc-rLIimSx2LRhAw==" rel="nofollow" target="_blank" rel="nofollow">Source Logistics</a>, a leading provider of warehousing, distribution, fulfillment, and freight services, has announced key leadership appointments that solidify its continued commitment to investment and growth. The company has promoted <a href="https://www.globenewswire.com/Tracker?data=MvkC3n-zMi6m0gLjc94kFoyrEQbKGn0fwx7iTGhB7ZCnLcEvZUQXZ4FTwpxOxXMBFZdsTKyM2PDhKgkv6unPFlqeuU05r4NoJ0sJTKaKAr2UtWS2rwAYQ2S3d2o4Rb6T" rel="nofollow" target="_blank" rel="nofollow">Barton Bullard</a> to Chief Technology Officer following <a href="https://www.globenewswire.com/Tracker?data=CSzBBv9nBrI63nIQk7sVKTy3jUtZOUR-c8rEkjxIbuqsT8MmMsw0MEUZyqk3Zd5NcqScBzHwj9g63-14vQ0NjNlT9Me-A98_O4XL_QAo84omveYsNaS9cPmu8X6oa9gu" rel="nofollow" target="_blank" rel="nofollow">Steve Edmondson</a> joining as the new Chief Commercial Officer earlier this year.</p> <p align="left">Barton Bullard's promotion to CTO signals Source Logistics' continued investment in technology as a core driver of its growth strategy. Bullard's leadership will be central to advancing the company's digital capabilities, systems integration, fraud prevention, and infrastructure modernization as the network continues to scale.</p> <p align="left">As Chief Commercial Officer, Steve Edmondson is leading Source Logistics' commercial strategy, with responsibility for accelerating revenue growth, expanding customer relationships, and building a scalable, integrated go-to-market engine. He brings more than two decades of executive commercial leadership experience to the role, having previously ...</p><p><a href=https://www.benzinga.com/pressreleases/26/06/g52968866/source-logistics-appoints-bart-bullard-as-chief-technology-officer-to-strengthen-leadership-team-a?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel alt=Source Logistics Appoints Bart Bullard as Chief Technology Officer to Strengthen Leadership Team and Support Rapid Expansion>Full story available on Benzinga.com</a></p> News Management Press Releases Wed, 03 Jun 2026 13:30:00 +0000 Globe Newswire 52968866 at https://www.benzinga.com Crop Protection Chemical Market to Reach $106.26 Billion by 2030 at 5.0% CAGR https://www.benzinga.com/pressreleases/26/06/g52968862/crop-protection-chemical-market-to-reach-106-26-billion-by-2030-at-5-0-cagr?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>Delray Beach, FL, June 03, 2026 (GLOBE NEWSWIRE) -- According to MarketsandMarkets™, the <a href="https://www.globenewswire.com/Tracker?data=lHE-81wKgVxIbGP86tsB9qvnD2yrlqAq8hKFwNCVOrzLTdok6qeHMAvqssVTS8t6vypyXWikxYAawJgG5jA6AEhnPPjw3bqjB914cnTFQAvG9XnGzaUoLGZPf2CGEtUptumhqEC-HWV-L0FBfJNYmfE0PZVNNX0CMaYBcOsLJmTBHH6zFhB6Gkwt_-kOlgpvy1u9HHmLMywpghUYEHlqJqlJL3ms5GG2Oex0Afu5hTJ2lXbEyQD23gySZDUBAYPqBUEfhNr44Qx9xGbJVGdfxQymkaUp0iO02VRi-l_knm4=" rel="nofollow" target="_blank" rel="nofollow"><b>global crop protection chemicals market</b></a> is estimated at USD 83.32 billion in 2025 and is projected to reach USD 106.26 billion by 2030, at a CAGR of 5.0% from 2025 to 2030.</p> <p><b>Crop Protection Chemicals Market Size & Forecast:</b></p> <ul type="disc"> <li style="margin-top:0in; margin-bottom:8pt;">2025 Market Size: USD 83.32 billion</li> <li style="margin-top:0in; margin-bottom:8pt;">2030 Projected Market Size: USD 106.26 billion</li> <li style="margin-top:0in; margin-bottom:8pt;">CAGR (2025–2030): 5.0%</li> </ul> <p><b>Asia Pacific Emerges as a Key Hub for Crop Protection Chemicals</b></p> <p>The Asia Pacific region holds a significant share of the crop protection chemical market due to its vast agricultural base, high cropping intensity, and strong reliance on agriculture for food security and rural livelihoods. Important staple crops, mainly rice, wheat, maize, and pulses, which are produced largely on a global scale, do require regular management pertaining to weeds, pests, and diseases. Smallholder-style dominant farming systems, varied cropping cycles, and year-round cultivation in many countries increase the frequency of crop protection chemical use. Besides, rapid population increases and rising food consumption drive governments and farmers to focus on yield stability and loss prevention. Enhancing access to crop protection inputs, strengthening distribution networks, and increasing adoption of modern farming practices tend to offer great demand across key markets, including China, India, Southeast Asia, and Australia.</p> <p><a href="https://www.globenewswire.com/Tracker?data=wUyZ-2NlAhBDs8biL3X9W4tLc1W5vF7-xgE5OtiwIYXUrxjLdiHgcqEhjCDaBZxY2JpTBcH0DxScEPR1A1MlmMttKipIQfArLSb3EWQ3Ssi6wQ6aXkM_l7Owz4Jix_R9bmI6g2A6AUtlXfyW59snZ__0b9_e0saup5wt8sL5xDDcie4ETp1BIhie5obkgDHohCFOwB-VIliqQL_JP8ukh4OGtUI7HY_T08lkVDaHnMWiEZvNljeQQBLuFhrrW688oFFzD7N6PnXGylxe8t2MnhifZy2cz2476nL5yKCLfhibnjsCxIxGaVEihcM_OKVz" rel="nofollow" target="_blank" rel="nofollow"><b>Request Custom Data to Address your Specific Business Needs</b></a></p> <p><b>Growing Adoption of Soil Treatment Drives Market ...</b></p><p><a href=https://www.benzinga.com/pressreleases/26/06/g52968862/crop-protection-chemical-market-to-reach-106-26-billion-by-2030-at-5-0-cagr?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel alt=Crop Protection Chemical Market to Reach $106.26 Billion by 2030 at 5.0% CAGR>Full story available on Benzinga.com</a></p> News Management Press Releases Wed, 03 Jun 2026 13:30:00 +0000 Globe Newswire 52968862 at https://www.benzinga.com Slick City Action Park Names Josh Cole Chief Marketing Officer https://www.benzinga.com/pressreleases/26/06/g52968658/slick-city-action-park-names-josh-cole-chief-marketing-officer?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>CHESTERFIELD, Mo., June 03, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=xxbTDGgvPV3HtMzAIUnY0UJcmMWo3LvGB8iGvYFUSNihJoVGJ38oAekNyNb2Ryz_4UNgsH685WcBYUxz2RkUo_-xyzHM5IUNYaIzZGwR4JI=" rel="nofollow" target="_blank" rel="nofollow"><u>Slick City Action Park</u></a>, the world's first indoor slide and action park featuring proprietary dry-slide technology, today announced the appointment of Josh Cole as its first Chief Marketing Officer. Cole joins the company's executive leadership team as Slick City continues its rapid expansion across North America and internationally, with 40 parks now open and 110 more in development.</p> <p>Cole brings more than two decades of experience building high-growth consumer and franchise brands. He has served as Chief Marketing Officer for leading experiential and franchise concepts including Sky Zone, TITLE Boxing Club and Sandbox VR, and previously held leadership roles with Universal Studios.</p> <p>"Josh has been part of the Slick City story from almost the beginning," said Bron Launsby, CEO and Co-Founder of Slick City. "He began advising our team when we had just two locations open and played a strategic role in helping establish the foundation for our franchise growth. As we scale nationally and internationally, bringing Josh into the organization full-time is a natural next step. His track record of building category-defining brands and supporting franchisees at scale makes him uniquely qualified to help lead Slick City's next chapter."</p> <p>Cole previously served as a strategic advisor to Slick City and brings extensive experience scaling consumer and franchise brands. As CMO of Sky Zone, he ...</p><p><a href=https://www.benzinga.com/pressreleases/26/06/g52968658/slick-city-action-park-names-josh-cole-chief-marketing-officer?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel alt=Slick City Action Park Names Josh Cole Chief Marketing Officer>Full story available on Benzinga.com</a></p> News Management Press Releases Wed, 03 Jun 2026 13:20:00 +0000 Globe Newswire 52968658 at https://www.benzinga.com Moburst Strengthens Leadership Team with Hire of Melissa Gruhin as Vice President of Creative https://www.benzinga.com/pressreleases/26/06/g52967916/moburst-strengthens-leadership-team-with-hire-of-melissa-gruhin-as-vice-president-of-creative?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=a2ExXnFwfydtkC2TKcQlUCLR-oJu2RcMRaHHyHIRWGPyLnrMB0HzOsKtcfUyBGDK21cwFezFosdWiWDPtJqpyg==" rel="nofollow" target="_blank" rel="nofollow"><u>Moburst</u></a>, a leading full-service mobile-first digital marketing agency, today announces the hiring of Melissa Gruhin as vice president of creative, strengthening its leadership team as clients seek to connect performance marketing with immersive storytelling.</p> <p>Gruhin brings more than a decade of experience across creative strategy, content development and digital execution, with work spanning global entertainment, technology, hospitality, lifestyle and financial services brands. Her experience includes campaigns and strategic work for Netflix, Hulu, HBO Max, the Grammys, Marriott Bonvoy, Hard Rock Hotels, Sonos, Armani Exchange and Citibank. Most recently, she held senior leadership roles at top creative agencies, including vice president of digital strategy and analytics at BMF and founder and chief strategy officer at Two Halves.</p> <p>As vice president of creative, Gruhin will lead Moburst's creative department and guide the agency's continued evolution from a performance-driven growth agency to a full-funnel AI growth operating system built to help brands grow audiences, strengthen equity and convert attention into measurable business impact.</p> <p>"Melissa brings the kind of creative leadership that today's market demands: strategic, culturally fluent and deeply accountable to results," said Gilad Bechar, CEO of Moburst. "Moburst has always been known for helping brands grow. With Melissa leading ...</p><p><a href=https://www.benzinga.com/pressreleases/26/06/g52967916/moburst-strengthens-leadership-team-with-hire-of-melissa-gruhin-as-vice-president-of-creative?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel alt=Moburst Strengthens Leadership Team with Hire of Melissa Gruhin as Vice President of Creative>Full story available on Benzinga.com</a></p> News Management Press Releases Wed, 03 Jun 2026 13:00:00 +0000 Globe Newswire 52967916 at https://www.benzinga.com JenaValve Appoints Maria Jose Arana as Vice President of Quality and Compliance https://www.benzinga.com/pressreleases/26/06/g52967862/jenavalve-appoints-maria-jose-arana-as-vice-president-of-quality-and-compliance?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>IRVINE, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of Maria Jose Arana as Vice President of Quality and Compliance. Maria Jose will lead the company's quality assurance and compliance strategy, overseeing the implementation of critical quality and compliance systems as JenaValve expands its commercial operations and advances its clinical programs. Her appointment continues the company's commitment to quality and patient safety during a pivotal period of organizational growth and commercial expansion following the recent FDA approval of the Trilogy THV System for high risk, symptomatic, severe aortic regurgitation (ssAR).</p> <p>Maria Jose brings more than 25 years of executive leadership experience in quality and regulatory affairs across medical devices, diagnostics, and combination product environments. She has a proven track record of building and scaling compliant Quality Management Systems (QMS), advancing regulatory workflows, and leading global inspection readiness programs across organizations.</p> <p>Most recently, Maria Jose served as Senior Director of Quality & Compliance at Johnson & Johnson Electrophysiology, where she led global Quality Systems, Compliance, and Quality Engineering organizations of more than 300 employees across cardiovascular device portfolios spanning predevelopment through commercialization. Prior to J&J, she served as Head of Quality & Compliance at Accriva Diagnostics, leading global QMS and validation teams across multiple markets. She also held quality and regulatory leadership roles at Volcano Corporation, CryoCor, and Medtronic Vascular. Maria Jose holds ...</p><p><a href=https://www.benzinga.com/pressreleases/26/06/g52967862/jenavalve-appoints-maria-jose-arana-as-vice-president-of-quality-and-compliance?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel alt=JenaValve Appoints Maria Jose Arana as Vice President of Quality and Compliance>Full story available on Benzinga.com</a></p> News Management Press Releases Wed, 03 Jun 2026 13:00:00 +0000 Globe Newswire 52967862 at https://www.benzinga.com